Continuous Renal Replacement Therapy (CRRT) Urological and Genital Diseases Continuous Renal Replacement Therapy (CRRT)
Conditions
Interventions
Patients are treated with a maximum five filters.
Please note that the study period of this trial has been extended to December 2007.
Sponsors
Gambro Industries (France)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients requiring Continuous Renal Replacement Therapy (CRRT) 2. Patients aged 18 and over 3. Patients weighing 30-120 kg 4. Patients having signed a written consent (informed consent) to participate in the study or written consent from a relative or, failing which, a person of trust in case the patient is unconscious
Exclusion criteria
Exclusion criteria: 1. History of heparin antibodies or heparin-induced thrombocytopenia 2. Known hypersensitivity to any dialysis membrane 3. Pregnancy 4. Current enrolment in another trial which could impact the successful completion of this study 5. Patients under guardianship 6. Patients anticipated to require transportation outside the unit for diagnostic or therapeutic procedures in the coming first week 7. Unconscious patients for whom no relative or person of trust can give consent for treatment. In the absence of any relative or person of trust, the patient in question cannot be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of filters? lifespan in patients treated by CRRT with the new products without any addition of heparin in the extracorporeal circuit | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment of heparin-free treatment | — |
Countries
France
Outcome results
None listed